Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,149.50    10.50 (0.92%)
Bid:
1,148.50
Ask:
1,149.50
Spread: 1.00 (0.087%)
Market Cap: £9.76b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

9 May 2019 15:14

RNS Number : 5624Y
Smith & Nephew Plc
09 May 2019
Β 

Β 

SMITH & NEPHEW PLC

Β 

9 May 2019

Β 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Graham Baker

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

Β 

ISIN: GB0009223206

b)

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2018 final dividend payment on 8 May 2019.

c)

Price(s) and volume(s)

Price(s)

Β£16.2523

Volume(s)

26

d)

Aggregated information

- Aggregated volume

- Price

Single Transaction

N/A

N/A

e)

Date of the transaction

2019 - 05 - 09

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

Β 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Anne-Marie Baker

2

Reason for the notification

a)

Position/status

PCA of Graham Baker, Chief Financial Officer

b)

Initial notification /Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Smith & Nephew plc

b)

LEI

213800ZTMDN8S67S1H61

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Smith & Nephew plc ordinary shares of USD 0.20 each

Β 

ISIN: GB0009223206

b)

Nature of the transaction

Purchase of ordinary shares through the Company's Dividend Re-Investment Plan following the 2018 final dividend payment on 8 May 2019.

c)

Price(s) and volume(s)

Price(s)

Β£16.2527

Β£16.1335

Volume(s)

15

63

d)

Aggregated information

- Aggregated volume

- Price

Β 

78

Β£16.1564

e)

Date of the transaction

2019 - 05 - 09

f)

Place of the transaction

London Stock Exchange (XLON)

Β 

Β 

Susan Swabey

Company Secretary

Smith & Nephew plc

Β 

Tel: 01923 477216

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
DSHLLFLSEFIAIIA
Date   Source Headline
18th Aug 20257:00 amRNSTransaction in Own Shares
15th Aug 20257:00 amRNSTransaction in Own Shares
14th Aug 20257:00 amRNSTransaction in Own Shares
13th Aug 20255:08 pmRNSDirector/PDMR Shareholding
13th Aug 20257:00 amRNSTransaction in Own Shares
12th Aug 20257:00 amRNSTransaction in Own Shares
11th Aug 20257:00 amRNSTransaction in Own Shares
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20254:30 pmRNSHolding(s) in Company
7th Aug 20253:15 pmRNSHolding(s) in Company
7th Aug 202510:34 amRNSDirector/PDMR Shareholding
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:01 amRNSShare Buyback Programme
5th Aug 20257:00 amRNSHalf-year Report
1st Aug 202510:21 amRNSTotal Voting Rights
21st Jul 202511:51 amRNSNotice of Results
11th Jul 202510:00 amRNSDirector/PDMR Shareholding
1st Jul 20251:30 pmRNSTotal Voting Rights
13th Jun 20257:00 amRNSDirectorate Change
6th Jun 20254:16 pmRNSDirector/PDMR Shareholding
2nd Jun 20252:07 pmRNSTotal Voting Rights
30th May 20251:22 pmRNSDirector/PDMR Shareholding
21st May 20253:00 pmRNSDirector/PDMR Shareholding
14th May 20257:00 amRNSSterling Amount of Dividend
7th May 202511:53 amRNSDirector/PDMR Shareholding
2nd May 202511:30 amRNSDirector/PDMR Shareholding
1st May 202511:27 amRNSTotal Voting Rights
30th Apr 20255:30 pmRNSResult of AGM
30th Apr 20257:00 amRNSSmith+Nephew First Quarter 2025 Trading Update
28th Apr 20251:49 pmRNSHolding(s) in Company
25th Apr 20259:18 amRNSDirectorate Change
22nd Apr 20257:00 amRNSNotice of Results
1st Apr 202512:41 pmRNSTotal Voting Rights
27th Mar 20259:17 amRNSDirector/PDMR Shareholding
27th Mar 20259:12 amRNSDirector/PDMR Shareholding
11th Mar 20253:25 pmRNSDirector/PDMR Shareholding
10th Mar 20252:46 pmRNSAnnual Financial Report
3rd Mar 20252:58 pmRNSTotal Voting Rights
25th Feb 20257:00 amRNSFinal Results
12th Feb 20257:11 amRNSBlock listing Interim Review
6th Feb 20257:00 amRNSNotice of Results
3rd Feb 202510:27 amRNSTotal Voting Rights
14th Jan 20257:00 amRNSDirectorate Change
2nd Jan 202512:51 pmRNSTotal Voting Rights
20th Dec 20249:46 amRNSDirector/PDMR Shareholding
16th Dec 202411:50 amRNSHolding(s) in Company
12th Dec 20249:53 amRNSHolding(s) in Company
11th Dec 20249:03 amRNSHolding(s) in Company
9th Dec 20243:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.